Activate the PKC/p38 pathway, reduce the infiltration and inhibitory function of myeloid‐derived suppressor cells (M‐MDSCs), promote their differentiation into antigen‐presenting cells, and increase the proportion of cDC1, thereby reshaping the tumor immune microenvironment. This evidence concerns the gene PRRT2 and neoplasm.